Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin oral solution versus tramadol for pediatric chronic neuropathic or mixed pain
NL-OMON45930Phase 3Active, not recruiting
- Sponsor
- Pharm
- Start
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Neuralgia and chronic pain comparing Gabapentin arm with Tramadol arm (2 arms). Primary endpoint: Average pain score at end of treatment. Started Jan 2017; status: active, not recruiting.
02
Drugs
gabapentintramadol
03
Conditions
Neuralgiachronic pain
Beyond the preview
Go deeper on NL-OMON45930.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON45930.